Session 2a: The Cancer Terminator: Our Immune System

​

10:30 - 10:35 Opening Remark

• − James Ding, General Partner and Managing Director, GSR Venture, LLP; Member, Council of the Future Forum
• 
  

10:35 - 11:05 Keynote Speech

Conceptual and practical advances in cancer immunotherapy

• − Lieping Chen, UTC Professor in Cancer Research; Professor of Immunobiology, Medicine and Dermatology; Director, Cancer Immunology Program, Yale University School of Medicine; Member, Academia Sinica
• 
  

11:05 - 11:35 Keynote Speech

Six steps of immune response

• − Yongjun Liu, Global Head of Research, Sanofi; Member, Science Committee of the Future Science Prize
• 
  

11:35 - 12:30 Panel

Moderator

• − Charlene Liao, PhD, President and CEO of Immune-Onc Therapeutics, Inc.
• 
  

Panelists

• − Lieping Chen (see above)
• − Jiuwei Cui, Director, Cancer Center, the First Hospital of Jilin University 
• − Yang-Xin Fu, Professor of Pathology, University of Texas, Southwestern Medical Center; Mary Nell and Ralph B. Rogers Professorship in Immunology
• − Yongjun Liu (see above)

Yuting Ma, Researcher, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences; PhD supervisor in Peking Union Medical College